Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 6 (2009), Issue 10 (October)

1. Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.
   J Am Soc Nephrol, 20(10): 2205-13. [Abstract] [Full-text]
2. DASH-style diet associates with reduced risk for kidney stones.
   J Am Soc Nephrol, 20(10): 2253-9. [Abstract] [Full-text]
3. Late cardiovascular complications after surgical or balloon angioplasty of coarctation of aorta in an Asian cohort.
   Am J Cardiol, 104(8): 1139-44. [Abstract] [Full-text]
4. Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).
   Am J Cardiol, 104(8): 1098-104. [Abstract] [Full-text]
5. Retinal artery occlusion: associated systemic and ophthalmic abnormalities.
   Ophthalmology, 116(10): 1928-36. [Abstract] [Full-text]
6. Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model.
   Value Health, 12(6): 857-71. [Abstract] [Full-text]
7. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study.
   Circ Cardiovasc Imaging, 2(5): 382-90. [Abstract] [Full-text]
8. Update in primary aldosteronism.
   J Clin Endocrinol Metab, 94(10): 3623-30. [Abstract] [Full-text]
9. Pregnancy-associated hypertensive disorders and adult cognitive function among Danish conscripts.
   Am J Epidemiol, 170(8): 1025-31. [Abstract] [Full-text]
10. Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity.
    Clin Exp Med, 9(4): 319-25. [Abstract] [Full-text]
11. Chronic hypertension aggravates heat stress-induced brain damage: possible neuroprotection by cerebrolysin.
    Acta Neurochir Suppl, 106: 327-33. [Abstract] [Full-text]
12. Different distribution patterns of cerebral microbleeds in acute ischemic stroke patients with and without hypertension.
    Eur Neurol, 62(5): 298-303. [Abstract] [Full-text]
13. Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.
    South Med J, 102(10): S1-S12. [Abstract] [Full-text]
14. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Circulation, 120(16): 1598-605. [Abstract] [Full-text]
15. Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.
    Clin Pharmacol Ther, 86(5): 533-9. [Abstract] [Full-text]
16. Strict blood-pressure control and progression of renal failure in children.
    N Engl J Med, 361(17): 1639-50. [Abstract] [Full-text]
17. Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
    Endocrinology, 150(11): 5027-35. [Abstract] [Full-text]
18. Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines.
    Hypertension, 54(5): 1136-42. [Abstract] [Full-text]
19. Environmental mercury exposure and blood pressure among Nunavik Inuit adults.
    Hypertension, 54(5): 981-6. [Abstract] [Full-text]
20. Mediterranean-style diet effect on the structural properties of the erythrocyte cell membrane of hypertensive patients: the Prevencion con Dieta Mediterranea Study.
    Hypertension, 54(5): 1143-50. [Abstract] [Full-text]
21. Hypertension correlates with lenticulostriate arteries visualized by 7T magnetic resonance angiography.
    Hypertension, 54(5): 1050-6. [Abstract] [Full-text]
22. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.
    Hypertension, 54(5): 1129-35. [Abstract] [Full-text]
23. Inhibition of 20-hydroxyeicosatetraenoic acid synthesis using specific plant lignans: in vitro and human studies.
    Hypertension, 54(5): 1151-8. [Abstract] [Full-text]
24. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.
    Hypertension, 54(5): 1084-91. [Abstract] [Full-text]
25. Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.
    Hypertension, 54(5): 1077-83. [Abstract] [Full-text]
26. Newly reported hypertension after military combat deployment in a large population-based study.
    Hypertension, 54(5): 966-73. [Abstract] [Full-text]
27. Renal impairment of pure autonomic failure.
    Hypertension, 54(5): 1057-61. [Abstract] [Full-text]
28. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study.
    Hypertension, 54(5): 974-80. [Abstract] [Full-text]
29. Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT).
    Hypertension, 54(5): 1009-13. [Abstract] [Full-text]
30. Influence of altered blood rheology on ventricular-vascular response to exercise.
    Hypertension, 54(5): 1092-8. [Abstract] [Full-text]
31. Blood pressure control determines improvement in diastolic dysfunction in early hypertension.
    Am J Hypertens, 22(11): 1227-31. [Abstract] [Full-text]
32. Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension.
    Circ Res, 105(9): 886-96. [Abstract] [Full-text]
33. Effects of diabetes mellitus, pressure-overload and their association on myocardial structure and function.
    Am J Hypertens, 22(11): 1190-8. [Abstract] [Full-text]
34. Relationship between self-reported sleep duration and changes in circadian blood pressure.
    Am J Hypertens, 22(11): 1205-11. [Abstract] [Full-text]
35. Proteinuria and clinical outcomes in hypertensive patients.
    Am J Hypertens, 22(11): 1137-47. [Abstract] [Full-text]
36. Association between morning blood pressure surge and cardiovascular remodeling in treated elderly hypertensive subjects.
    Am J Hypertens, 22(11): 1177-82. [Abstract] [Full-text]
37. Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers.
    Am J Hypertens, 22(11): 1160-6. [Abstract] [Full-text]
38. Alcohol consumption, hypertension, and total mortality among women.
    Am J Hypertens, 22(11): 1212-8. [Abstract] [Full-text]
39. Pulse pressure, prehypertension, and mortality: the San Antonio heart study.
    Am J Hypertens, 22(11): 1219-26. [Abstract] [Full-text]
40. Improving survival of malignant hypertension patients over 40 years.
    Am J Hypertens, 22(11): 1199-204. [Abstract] [Full-text]
41. Metoprolol succinate combination in the treatment of hypertension.
    Angiology, 60(5): 608-13. [Abstract] [Full-text]
42. Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence.
    Angiology, 60(5): 601-7. [Abstract] [Full-text]
43. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.
    Lancet, 374(9699): 1423-31. [Abstract] [Full-text]
44. Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study.
    Am J Kidney Dis, 54(5): 881-90. [Abstract] [Full-text]
45. The potency of team-based care interventions for hypertension: a meta-analysis.
    Arch Intern Med, 169(19): 1748-55. [Abstract] [Full-text]
46. A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload.
    Am J Physiol Heart Circ Physiol, 297(5): H1585-93. [Abstract] [Full-text]
47. Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism.
    Am J Physiol Heart Circ Physiol, 297(5): H1845-52. [Abstract] [Full-text]
48. Angiotensin II enhances GABA(B) receptor-mediated responses and expression in nucleus tractus solitarii of rats.
    Am J Physiol Heart Circ Physiol, 297(5): H1837-44. [Abstract] [Full-text]
49. Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.
    Am J Physiol Heart Circ Physiol, 297(5): H1638-46. [Abstract] [Full-text]
50. Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension.
    Am J Physiol Heart Circ Physiol, 297(5): H1567-75. [Abstract] [Full-text]
51. Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production.
    Am J Physiol Heart Circ Physiol, 297(5): H1647-54. [Abstract] [Full-text]
52. Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis.
    Clin Chem, 55(11): 2026-34. [Abstract] [Full-text]

© 2004-2010 Hypertension Research Today. All Rights Reserved.